Data from a huge federally sponsored analysis of health records are finally in, and the Food and Drug Administration isn't recommending any changes in safety instructions for medicines to treat attention deficit/hyperactivity disorder.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/04/08/135234171/fda-holds-off-on-heart-warnings-for-adhd-medicines?ft=1&f=103537970
Posted
Apr 08 2011, 06:59 AM
by
NPR Blogs: Shots - Health Blog